BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Spartalis M, Papagianni A. Receptor activator of nuclear factor κB ligand/osteoprotegerin axis and vascular calcifications in patients with chronic kidney disease. World J Nephrol 2016; 5(1): 1-5 [PMID: 26788459 DOI: 10.5527/wjn.v5.i1.1]
URL: https://www.wjgnet.com/2220-6124/full/v5/i1/1.htm
Number Citing Articles
1
Marcin Krzanowski, Katarzyna Krzanowska, Paulina Dumnicka, Mariusz Gajda, Karolina Woziwodzka, Danuta Fedak, Tomasz Grodzicki, Jan A Litwin, Władysław Sułowicz. Elevated Circulating Osteoprotegerin Levels in the Plasma of Hemodialyzed Patients With Severe Artery CalcificationTherapeutic Apheresis and Dialysis 2018; 22(5): 519 doi: 10.1111/1744-9987.12681
2
Peng Duan, Min Yang, Meilin Wei, Jia Liu, Ping Tu. Serum Osteoprotegerin Is a Potential Biomarker of Insulin Resistance in Chinese Postmenopausal Women with Prediabetes and Type 2 DiabetesInternational Journal of Endocrinology 2017; 2017: 1 doi: 10.1155/2017/8724869